This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

J. Crew, Athenahealth: Ratings Changes

BOSTON ( TheStreet) -- Here are three ratings changes from TheStreet's stock model.

3. The model downgraded Amerisafe (AMSF - Get Report) to "hold." Amerisafe is an insurer, selling workers' compensation insurance to small and mid-sized employers in hazardous industries such as construction, trucking and logging.

Quarter: Fourth-quarter net income increased 15% to $6.6 million, but earnings per share stalled at 28 cents. Revenue declined marginally. The operating margin narrowed from 17% to 14%. Amerisafe holds $118 million of cash and $36 million of debt.

Stock: Amerisafe has risen 6.4% during the past 12 months, trailing U.S. indices. The stock trades at a price-to-projected-earnings ratio of 8.3 and a price-to-book ratio of 1, 29% and 10% discounts to industry averages. It's expensive based on cash flow.

Consensus: Of analysts covering Amerisafe, five recommend purchasing its shares and four advise holding them. SunTrust Robinson Humphrey expects the stock to advance 49% to $24. Sidoti & Co. and Piper Jaffray also rate Amerisafe "buy."

2. The model downgraded Athenahealth (ATHN - Get Report) to "sell." Athenahealth offers Internet-based business services to physician practices. Its products help physicians flag billing errors, track new insurance rules and share information. Full-year profit fell 71%.

Quarter: Fourth-quarter profit tumbled 84% to $4.3 million, or 12 cents, hurt by one-time gains in the year-earlier period. Revenue jumped 33% to $54 million The operating margin extended to 15%. Athenahealth holds $83 million of cash and $12 million of debt.

Stock: Athenahealth has advanced 51% in the past year, more than the Dow Jones Industrial Average and S&P 500 Index. The stock sells for a price-to-projected-earnings ratio of 32 and a price-to-cash-flow ratio of 39, significant premiums to industry averages.

Consensus: Of researchers evaluating Athenahealth, nine rate its stock "buy," 12 rate it "hold" and four rank it "sell." Thomas Weisel offers a price target of $55, leaving a potential 51% upside. Deutsche Bank and Jefferies are also bullish on the shares.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
AMSF $44.51 -0.34%
ATHN $114.11 0.57%
AAPL $125.01 -0.63%
FB $78.10 0.70%
GOOG $524.22 -1.24%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs